Results 101 to 110 of about 20,777 (183)

Caso clínico: decisiones terapéuticas en la bulimia nervosa

La fluoxetina es el SSRI de elección en la bulimia nervosa, iniciando a 20 mg con posibles incrementos hasta 40-60 mg para una eficacia óptima. El bupropión debe evitarse en pacientes con bulimia nervosa debido al mayor riesgo de convulsiones asociado a ...
Scott Crow
core   +1 more source

Tirzepatide Persistence and Associated Changes in Clinical Outcomes in US Adults With Obesity or Overweight: A 6‐Month Claims Database Analysis

Diabetes, Obesity and Metabolism, Volume 28, Issue 11, Page 9966-9979, November 2026.
ABSTRACT Aims Tirzepatide is a once‐weekly glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) approved in the US for the treatment of Type 2 diabetes (T2D), weight loss and obstructive sleep apnoea. This study aimed to assess the utilisation and effectiveness of tirzepatide among individuals in a large ...
Theresa Hunter Gibble, Malvika Venkataraman, Donna Mojdami, Carlos Vallarino, Grace Stockbower, Michael Grabner, Mythili Ananth, Karishma Desai   +7 more
wiley   +1 more source

¿Qué antidepresivos producen mayor aumento de peso?

Entre los antidepresivos de prescripción habitual, escitalopram mostró el mayor aumento de peso en comparación con sertralina. Bupropión produjo una ligera pérdida de peso.
Paul Zarkowski
core   +1 more source

Pruebe con un segundo SSRI o una alternativa (nodo 4)

, 2018
Tras el fracaso de un SSRI inicial, un segundo SSRI es la recomendación estándar Los SSRI no son idénticos en su espectro de actividad sobre receptores Un SSRI diferente podría ofrecer una constelación de efectos más favorable Otras alternativas en este ...
Mercedes Guaia Memita Guaia
core   +1 more source

Efficacy of the cigarette-burning application combined with medication intervention for smoking cessation in China: A randomized controlled trial

Digital Health
Background Although smartphone application for smoking cessation was considered a promising strategy, there were scarce studies on the combination of usual interventions and apps for smoking cessation in China. Our study aimed to evaluate the efficacy of
Xiao-Wen Wei, Rui Qin, Yong-Zhuang Liu, Zhao Liu, An-Qi Cheng, Xin-Mei Zhou, Zheng Su, Zi-Yang Cui, Jin-Xuan Li, Liang Zhao, Dan Xiao, Chen Wang   +11 more
doaj   +1 more source

Dextromethorphan Hydrobromide‐Bupropion Hydrochloride for Agitation in Dementia: Combination or Two Stand‐Alone Drugs

Journal of the American Geriatrics Society, EarlyView.
Eric E. Brown, Todd Semla, David B. Reuben   +2 more
wiley   +1 more source

The Effect of Behavioral Sleep Interventions on Measures of Obesity, Dietary Intake and Physical Activity in Adults With Poor Sleep Health: A Systematic Review, Meta‐Analysis and Meta‐Regression Analysis

Obesity Reviews, Volume 27, Issue 11, November 2026.
ABSTRACT Background As poor sleep negatively impacts on adiposity, there is interest in examining whether improving sleep can improve adiposity markers. We reviewed studies aimed at improving sleep using (1) cognitive behavioral therapy for insomnia (CBT‐I) and/or sleep hygiene and (2) sleep extension on adiposity markers, dietary intake, and physical ...
Samiul A. Mostafa, Pushpa Singh, Feaz Babwah, Wasim Hanif, George Balanos, Krishnarajah Nirantharakumar, Jason G. Ellis, Abd A. Tahrani   +7 more
wiley   +1 more source

SAL0114: a novel deuterated dextromethorphan-bupropion combination with improved antidepressant efficacy and safety profile

Frontiers in Pharmacology
BackgroundEsketamine, the first Food and Drug Administration-approved fast-acting antidepressant, has limited use because of its addictive properties.
Ying Xiao, Xuefeng Hu, Wei Xing, Jie Yan, Ruhuan Wang, Xiaoqing Li, Jiahuan Li, Zhixin Zhang, Jingchao Sun, Junjun Wu   +9 more
doaj   +1 more source

Real‐World Outcomes of Telemedicine Shared Medical Appointments in Obesity Management

Obesity Science &Practice, Volume 12, Issue 5, October 2026.
ABSTRACT Introduction Shared Medical Appointments (SMAs) have recently emerged as a novel tool in weight management as they are efficient, bypass logistic barriers to physical attendance, decrease attrition, and are cost‐effective. This study aimed to observe outcomes among patients enrolled in an insurance‐based weight loss program, called Program for
Keerthana Haridas, Jeffrey Wei, Lei Lei, Derek Pham, Nicholas Jackson, Na Shen   +5 more
wiley   +1 more source

Algoritmo de tratamiento

, 2020
Las anfetaminas pueden ser ligeramente preferidas sobre el metilfenidato en el tratamiento del TDAH en adultos. Considerar la TCC para los déficits de función ejecutiva. En el trastorno por uso de sustancias comórbido, se deben usar no estimulantes antes
Mercedes Guaia Memita Guaia
core   +1 more source